China Resources Double-Crane Pharmaceutical Co.,Ltd. Share Price
Stocks
600062
CNE000000Q94
Pharmaceuticals
|
End-of-day quote
Shanghai S.E.
21/10/2026
|
5-day change | 1st Jan Change | ||
| 16.11 CNY | -0.92% |
|
-2.42% | -11.92% |
| 10-21 | CR Double-Crane Pharmaceutical Gets Registration Certificate for Baricitinib Tablets | MT |
| 10-20 | Double-Crane Pharmaceutical Subsidiary Gets China Approval for Hydrogen Phosphate Injection | MT |
| Market Cap | 16.64B 2.49B 2.22B 2.06B 1.86B 3.51B 235B 3.55B 24.65B 9.67B 124B 9.35B 9.15B 394B | P/E 2026 * |
9.42x | P/E 2027 * | 8.8x |
|---|---|---|---|---|---|
| Enterprise Value | 16.64B 2.49B 2.22B 2.06B 1.86B 3.51B 235B 3.55B 24.65B 9.67B 124B 9.35B 9.15B 394B | EV / Sales 2026 * |
1.46x | EV / Sales 2027 * | 1.39x |
| Free-Float |
37.31% | Yield 2026 * |
3.17% | Yield 2027 * | 3.29% |
| 1 day | -0.92% | ||
| 1 week | -2.42% | ||
| Current month | -0.80% | ||
| 1 month | -0.06% | ||
| 3 months | -5.68% | ||
| 6 months | -11.14% | ||
| Current year | -11.92% |
| 1 week | 16.04 |  | 16.66 |
| 1 month | 15.86 | | 16.66 |
| Current year | 15.29 | | 19.08 |
| 1 year | 15.29 | | 19.77 |
| 3 years | 14.8 | | 26.15 |
| 5 years | 11.25 | | 37.44 |
| 10 years | 10.66 | | 37.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wen Hao Huang
DFI | Director of Finance/CFO | 43 | 17/02/2025 |
Qian Zhao
PSD | President | 45 | 24/10/2024 |
Li Hong Zheng
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ning Liu
BRD | Director/Board Member | 68 | 29/05/2006 |
Mao Zhu Sun
BRD | Director/Board Member | 67 | 11/07/2021 |
Shu Tian Yu
BRD | Director/Board Member | 60 | 09/10/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/12/22 | Buy | Chairman | 5,000 | 0.0005% | ||
| 21/12/22 | Buy | Director | 10,000 | 0.0010% | ||
| 20/12/22 | Buy | Director | 5,000 | 0.0005% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.92% | -2.42% | -14.81% | +5.92% | 2.49B | |
| -1.01% | +5.13% | +58.93% | +117.36% | 1,133B | |
| -0.61% | +1.52% | +34.34% | +68.48% | 621B | |
| -1.48% | +0.47% | +23.08% | +94.76% | 503B | |
| -0.91% | +2.24% | +38.40% | +63.42% | 379B | |
| +1.07% | +1.70% | +71.06% | +45.98% | 370B | |
| +0.74% | +1.62% | +22.01% | +51.41% | 292B | |
| +0.26% | -0.44% | +0.81% | +25.17% | 262B | |
| -0.14% | +2.87% | +45.56% | +57.22% | 237B | |
| -1.88% | +0.02% | +23.77% | +97.39% | 190B | |
| Average | +0.15% | +2.75% | +30.32% | +62.71% | 399.05B | |
| Weighted average by Cap. | +0.54% | +3.73% | +40.71% | +79.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 11.39B 1.71B 1.52B 1.41B 1.27B 2.4B 161B 2.43B 16.88B 6.62B 84.64B 6.4B 6.27B 270B | 11.98B 1.79B 1.6B 1.48B 1.34B 2.52B 169B 2.55B 17.74B 6.96B 88.97B 6.73B 6.59B 284B |
| Net income | 1.78B 266M 237M 219M 199M 374M 25.1B 379M 2.63B 1.03B 13.19B 998M 977M 42.04B | 1.9B 285M 254M 235M 212M 400M 26.85B 405M 2.81B 1.1B 14.11B 1.07B 1.05B 44.98B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/10/26 | CN¥16.11 | -0.92% | 5,061,944 |
| 20/10/26 | CN¥16.26 | -1.09% | 8,061,100 |
| 19/10/26 | CN¥16.44 | +0.43% | 5,657,500 |
| 16/10/26 | CN¥16.37 | +0.18% | 8,305,200 |
| 15/10/26 | CN¥16.34 | -1.03% | 7,954,135 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600062 Stock
Select your edition
All financial news and data tailored to specific country editions
